TickerFacts.

Castle Biosciences Inc (CSTL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$2.04M
Year ended 2025-12-31
-$16.52M
Trailing 12 months to 2026-06-30
$24.67M2020-12-31: -$6.07M2021-12-31: -$36.67M2022-12-31: -$62.31M2023-12-31: -$55.65M2024-12-31: $24.67M2025-12-31: -$2.04M-$2.04M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$2.04Mn/m2026-02-26, From 2025-01-01
2024-12-31$24.67Mn/m2026-02-26, From 2024-01-01
2023-12-31-$55.65Mn/m2026-02-26, From 2023-01-01
2022-12-31-$62.31Mn/m2025-02-27, From 2022-01-01
2021-12-31-$36.67Mn/m2023-02-28, From 2021-01-01
2020-12-31-$6.07Mn/a2022-02-28, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Castle Biosciences Inc (CSTL)2025-12-31-$2.04Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$66.97Mn/m
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$22.92Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$67.73Mn/m
Guardant Health, Inc. (GH)2025-12-31-$397.51Mn/m
Biodesix Inc (BDSX)2025-12-31-$22.20Mn/m
Personalis, Inc. (PSNL)2025-12-31-$78.01Mn/m

Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗